Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Gore & Associates

evt | Article | February 2018 Supplement

The When and How of PAD Treatment: A Roundtable Discussion

A panel of PAD experts talk through the patient-specific factors and technical nuances that influence outcomes.

With Dennis Gable, MD, FACS, RVT; Robert E. Beasley, MS, MD; Russell H. Samson, MD, FACS, RVT; and Darren B. Schneider, MD, FACS

Sponsored by Gore & Associates

evt | Article | March 2017 Supplement

Trust is Earned: Insights From the 5,000 Patients Enrolled in GREAT

An overview of early data on the outcomes of this multicenter, prospective registry for all commercially available Gore aortic endografts.

By Ross Milner, MD, FACS, and Dennis Gable, MD, RVT, FACS

evt | News | November 5, 2013

FDA Approves 25-cm Gore Viabahn Endoprosthesis to Treat Long-Segment SFA Lesions

November 6, 2013—Gore & Associates (Flagstaff, AZ) announced that the US Food and Drug Administration (FDA) has approved the 25-cm Gore Viabahn endoprosthesis with heparin bioactive surface for the treatment of symptomatic peripheral arterial disease lesions in the superficial femoral artery (SFA).

Sponsored by Medtronic

evt | Article | August 2015 Supplement

Why Build an Aortic Center?

By Frank R. Arko III, MD, and Dennis R. Gable, MD, RVT

Advertisement

Sponsored by Gore & Associates

evt | Article | March 2018 Supplement

LSA Preservation During TEVAR: Insights From the International GREAT Registry

An overview of our experience with the Conformable GORE® TAG® Thoracic Endoprosthesis.

By Dennis R. Gable, MD, and William T. Brinkman, MD

evt | News | June 17, 2015

GREAT Global Registry Data Presented for Gore's Endovascular Devices

June 18, 2015—Gore & Associates announced that data from the GREAT (Gore Global Registry for Endovascular Aortic Treatment) real-world endovascular outcomes registry were presented at the Society for Vascular Surgery’s 2015 Vascular Annual Meeting held June 17–20 in Chicago, Illinois.  The company also noted that the GREAT registry has passed the enrollment milestone of 3,000 patients.

Sponsored By Surmodics, Inc.

evt | Article | December 2023 Supplement

CASE REPORT
Successful Removal of an SMA Embolus With the Pounce™ Thrombectomy System

By Nate Mohr, MD, and Dennis Fry, MD

evt | News | October 14, 2020

GNT Pharma Reports Results From Phase 2 SONIC Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

October 14, 2020—GNT Pharma Inc., a South Korea–based developer of drug and technology for the treatment of patients with neurological and inflammatory diseases, reported top-line results from the phase 2 SONIC study assessing the safety and efficacy of nelonemdaz in acute ischemic stroke patients treated with endovascular thrombectomy within 8 hours of symptom onset.

evt | Article | July 2006

An Interview With Mark W. Mewissen, MD

A renowned vascular radiologist shares his wisdom about the state of the practice, SFA stenting, and online education.

By Mark W. Mewissen, MD

Sponsored by Penumbra, Inc.

evt | Article | April 2023

The Value of the Penumbra Coils in Trauma Management

Demonstrating the application of Ruby and Packing Coils for trauma embolisation with case examples.

With Florian Wolf, MD, MBA, FCIRSE, EBIR, EBCR; Conrad von Stempel, MBBS; Andrea Discalzi, MD, EBIR; and Denis Rossato, MD

evt | Article | July 2019

Panel Discussion: The Case for Robust Screening Programs for Venous Leg Ulcers

A multidisciplinary panel discusses educating providers about early reflux elimination, VLU diagnosis mistakes, identifying appropriate candidates, the potential downsides of large-scale screening programs, and more.

With William Ennis, DO; Manjit Gohel, MD, MBChB, FRCS, FEBVS; Neil Khilnani, MD, FSIR, FACPh; Raghu Kolluri, MS, MD, RVT, FSVM; and Kathleen Ozsvath, MD

evt | Article | October 2007

Varicose and Telangiectatic Leg Veins

Principles for successful sclerotherapy treatment of varicose and telangiectatic leg veins.

By Mitchel P. Goldman, MD

evt | News | November 8, 2015

Medtronic Launches the VenaSeal Closure System to Treat Venous Reflux in United States

November 9, 2015—Medtronic plc announced the launch of the VenaSeal closure system in the United States.

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button